Post by Anvita Karara
Leading the AI-Powered Future of Biopharma Commercialization | VP, Commercialization AI Strategy & Analytics at Bristol Myers Squibb
What happens when you combine AI innovation, market insight, and deep human connection—across borders? I recently had the opportunity to visit our teams in Germany and the UK, and I came away both inspired and energized by what I saw and heard on the ground. In Germany, we leaned into shared learning —especially as the market faces a wave of competitive entrants. The urgency for transformation was clear, but so was the momentum. In the UK, I was reminded that innovation is only as strong as the people behind it.🎾 From joining a “Centre Court” fireside chat (where I was asked, what's your favorite day of the week? – it’s Friday 😄)... 🍽️ ...to connecting over dinner learning about their AI-driven ideas like the “Advanced AI” approach... This trip reinforced -The power of in-person connection is unmatched and The future of commercialization will be built at the intersection of innovation, people, and bold thinking! Thank you to our Germany and UK colleagues for the warm welcome, openness, and showcasing innovation with heart. Special thanks to Remo Gujer Dr. Konstanze Wagner Lora Chio and Megan Ax! Let’s keep pushing boundaries—together. Be AI-curious. Be people-first. Be future-ready. #ProudToBeBMS